Health Bulletin 10/September/2022 Roshni Dhar10 Sept 2022 5:14 PM ISTHere are the top health news for the day:Pharma association gives clean chit to Dolo-makerMaker of Dolo 650, Micro Labs which landed in...
Pfizer secures USFDA Breakthrough Therapy designation for Group B Streptococcus Vaccine Ruchika Sharma8 Sept 2022 1:00 PM ISTGroup B Streptococcus (GBS) is a common bacterium that can cause potentially devastating diseases in infants, including sepsis, pneumonia and...
Pfizer-BioNTech bivalent booster for Omicron, original COVID strain gets UK nod Ruchika Sharma5 Sept 2022 12:45 PM ISTIn each dose of the booster vaccine called "Comirnaty bivalent Original/Omicron", half of the vaccine (15 micrograms) targets the original virus...
Pfizer, BioNTech seek to revoke CureVac patent infringement claims Ruchika Sharma4 Sept 2022 4:51 PM ISTNew Delhi: Pfizer and its German partner BioNTech have filed proceedings at the High Court of England and Wales, seeking a judgment that their...
Pfizer gets CDSCO panel nod to import, market Tofacintib for active ankylosing spondylitis Dr. Divya Colin2 Sept 2022 6:00 PM ISTNew Delhi: Pharmaceutical major, Pfizer, has got a go ahead from the Subject Expert Committee(SEC) functional under the Central Drug Standard Control...
Pfizer-BioNTech gets USFDA emergency use nod for Omicron BA.4/BA.5-Adapted Bivalent COVID vaccine booster for 12 years and older Ruchika Sharma2 Sept 2022 2:00 PM ISTThe Pfizer-BioNTech COVID-19 Vaccine, which is based on BioNTech's proprietary mRNA technology, was developed by both BioNTech and Pfizer.
Alleging patent infringement, Moderna sues Pfizer-BioNtech over use of mRNA technology in COVID vaccine Ruchika Sharma27 Aug 2022 5:00 PM ISTPfizer said the company was confident in its intellectual property and would vigorously defend against the allegations.
COVID vaccine 73.2 percent effective in children under 5: Pfizer Ruchika Sharma24 Aug 2022 4:30 PM ISTThe Pfizer-BioNTech COVID-19 Vaccine, which is based on BioNTech's proprietary mRNA technology, was developed by both BioNTech and Pfizer.
AstraZeneca may not stay in vaccine business in long run: CEO Ruchika Sharma24 Aug 2022 2:57 PM ISTAstraZeneca is also looking for bolt-on acquisitions, including small and mid-sized companies specialising in oncology and cardiovascular treatments,...
Aurobindo Pharma arm bags USFDA nod for Medroxyprogesterone Acetate Injectable Suspension Ruchika Sharma24 Aug 2022 12:25 PM ISTHyderabad: Drugmaker, Aurobindo Pharma Limited, today announced that its wholly-owned subsidiary company, Eugia Pharma Specialties Limited, has...
Pfizer, BioNTech seek USFDA emergency use nod for Omicron adapted COVID booster dose for 12 years of age and older Ruchika Sharma23 Aug 2022 11:32 AM ISTThe bivalent vaccine contains mRNA encoding the original SARS-CoV-2 spike protein, which is present in the original Pfizer-BioNTech COVID-19 Vaccine,...
Test second Paxlovid course in patients with COVID rebound: USFDA asks Pfizer Ruchika Sharma21 Aug 2022 11:30 AM ISTBengaluru: The U.S. Food and Drug Administration (USFDA) has asked Pfizer Inc to test the effects of an additional course of its antiviral Paxlovid...
